October 18, 2023
UC San Diego engineers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. Its success lies in targeting a protein known to play a central role in cancer growth and spread, rather than targeting the primary tumor itself.
March 27, 2012
Four engineering faculty members with technology transfer success stories discussed the challenges of the commercialization process during a March 14 dinner celebrating the 10th anniversary of the von Liebig Center for Entrepreneurism and Technology Advancement. The von Liebig Center offers seed funding and advisory services and is part of the…
March 12, 2012
A 200-patient Phase 2 clinical pilot study will be initiated this month to test the efficacy and safety of a new use, and method of administering, an enzyme inhibitor for critically ill patients developed by University of California, San Diego Bioengineering Professor Geert Schmid-Schönbein.
March 1, 2016
Chronic psychosocial and emotional stress has well-documented negative effects upon the human immune system but less is known about the health effects of acute but transitory episodes of stress. Do panic-inducing moments also raise the risk of stress-related conditions? A team of researchers at University of California, San Diego School…
July 28, 2014
A study of juvenile rat brain cells suggests that the effects of a commonly used anesthetic drug on the connections between brain cells are temporary.
November 12, 2020
…ultimately leading to chronic inflammation associated with non-alcoholic fatty liver disease (NAFLD). Pradipta Ghosh and team discovered that a molecule called GIV acts as a brake on macrophages, keeping them in check. The researchers can also mimic GIV as a means to reduce inflammation in cases where it’s detrimental, such…
December 17, 2019
In a UC San Diego study, rats with spinal cord injuries experienced a three-fold increase in motor activity when treated with neural progenitor cells that had been pre-conditioned with a modified form of tPA, a drug commonly used to treat non-hemorrhagic stroke.
February 1, 2016
Twenty-two University of California, San Diego scientists and physicians are among the 2015 listing of “The World’s Most Influential Scientific Minds,” an annual compendium of “Highly Cited Researchers” by Thomson Reuters, a multinational mass media and information company.
June 6, 2022
UC San Diego researchers report that the causes and death rates of liver cancer are changing around the world.
February 11, 2020
UC San Diego and IBM researchers reveal a new understanding of how our microbiomes change as we age, setting the stage for future research on the role microbes play in accelerating or decelerating the aging process and influencing age-related diseases.
